The association between the expression of solute carrier transporters and the prognosis of pancreatic cancer

Abstract

The aim of this study was to investigate the prognostic significance of fourteen anticancer drug-relevant solute carrier transporters (SLCs) in pancreatic cancer in the context of clinical-pathological characteristics and the KRAS mutation status of tumors.

Keywords

• Pancreatic cancer
• SLC transporters
• Gene expression
• Survival
• KRAS